| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $272.5M | -3.4% |
| SG&A Expense | $71.6M | -9.2% |
| Operating Income | -$280.5M | +17.6% |
| Pre-tax Income | -$228.3M | +32.9% |
| Income Tax | $12K | -73.9% |
| Net Income | -$228.3M | +32.9% |
| EPS (Basic) | -$2.24 | +38.3% |
| EPS (Diluted) | -$2.24 | +38.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $92.9M | -12.4% |
| Short-term Investments | $149.9M | -43.4% |
| Accounts Receivable | $40.2M | +3979.2% |
| Inventory | $1.6M | — |
| Current Assets | $295.1M | -23.3% |
| Total Assets | $376.4M | -19.6% |
| Current Liabilities | $78.9M | -25.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$270.4M | -22.6% |
| Capital Expenditures | $4.2M | -60.4% |
| Investing Cash Flow | $203.0M | +811.8% |
| Financing Cash Flow | $53.1M | -48.9% |
| Free Cash Flow | -$274.6M | -18.8% |
| Total Liabilities |
| $249.8M |
| +32.5% |
| Stockholders' Equity | $126.6M | -54.7% |